Prelude Capital Management’s Inventiva IVA Stock Holding History

Prelude Capital Management’s Portfolio IVA Stock Details IVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-40,000	Closed	-$222K	–	1389
2026 Q1	$222K	Buy	+40,000	New	+$244K	0.02%	861

Other funds holding IVA

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Andera Partners Paris $206M AUM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Millennium Management

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Franklin Resources

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Squadron Capital Management Westmont, Illinois $322M AUM

Prelude Capital Management's IVA Position: Q2 2026 in Review

Prelude Capital Management sold out of Inventiva (IVA) in Q2 2026, closing a stake of 40,000 shares — an estimated $222K sold.

Prelude Capital Management first reported a position in IVA in Q1 2026 and held it in 1 quarter. The position peaked at $222K in Q1 2026. 88 funds tracked by Wall St. Rank hold IVA as of Q2 2026.

Prelude Capital Management reported no remaining Inventiva position as of Q2 2026 after selling out during the quarter.
Prelude Capital Management sold 40,000 Inventiva shares in Q2 2026, an estimated $222K.
Prelude Capital Management first reported a position in Inventiva in Q1 2026 and held it in 1 quarter.
Prelude Capital Management's Inventiva position peaked at $222K in Q1 2026.
88 funds tracked by Wall St. Rank held Inventiva as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.